Suzhou Zelgen Biopharmaceuticals Co., Ltd. (SHA:688266)
100.69
+7.36 (7.89%)
At close: Mar 27, 2026
12.88% (1Y)
| Market Cap | 26.65B +22.7% |
| Revenue (ttm) | 810.48M +52.1% |
| Net Income | -162.95M |
| EPS | -0.62 |
| Shares Out | 264.71M |
| PE Ratio | n/a |
| Forward PE | 114.64 |
| Dividend | n/a |
| Ex-Dividend Date | n/a |
| Volume | 5,158,088 |
| Average Volume | 3,435,467 |
| Open | 92.55 |
| Previous Close | 93.33 |
| Day's Range | 92.13 - 101.99 |
| 52-Week Range | 75.10 - 134.17 |
| Beta | 0.20 |
| RSI | 69.60 |
| Earnings Date | Mar 28, 2026 |